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To the Editor: Following up on our previous report,1 we
provide further details on clinical investigations in several
cases of rapidly fatal encephalitis that have come to attention in
Pretoria during the past 4 - 5 years. All but one of the patients
were children who presented initially with features of viral
encephalitis.
The first case, an adult woman, died 3 weeks after her dog
died of biliary fever.  Unfortunately no further clinical history
is available.
The second case, a 6-year-old boy, died within a week of
admission to hospital with a clinical picture of encephalitis.  He
presented initially with a history of headache and fever.  He
was admitted to a private clinic but was discharged after his
clinical picture improved.  His condition subsequently
deteriorated.  He had gait disturbances (ataxia) and progressive
sleepiness.  He was admitted again, but deteriorated rapidly
and became comatose.  He was intubated and transferred to an
intensive care unit, where he died about 3 days later.  A
computed tomography (CT) scan of the brain performed at this
stage revealed oedema and hypodense lesions in the cortex.  
A lumbar puncture performed on admission revealed only
occasional lymphocytes.  Nothing was cultured from the
cerebrospinal fluid or from blood cultures.   The white cell
count was raised (19.8 x 109/l), with a platelet count of 489 x
109/l.  Serological examination revealed nothing except an
Rickettsia conori immunoglobin M titre of 1:128, which is not
regarded as positive.  The child died before the test could be
repeated.  A postmortem examination was requested.
The postmortem was unremarkable.  The only positive
findings were pulmonary oedema and an oedematous,
hyperaemic brain. Hyperaemia of the brain is consistent with
encephalitis.  Histological examination revealed extensive
vasculitis in the brain, most prominent in the midbrain and
pons.  Foci of associated necrosis were seen.  After extensive
enquiries it emerged that no history of a skin rash or eschar
had ever been obtained.  Given the above history, numerous
methods to demonstrate organisms/pathogens were explored.
Rickettsiae are fairly large organisms, which can be
demonstrated with silver stains.  Repeated silver stains of the
brain sections were negative.  Electron microscopic
examination of the vasculitic lesions was also negative.
Given the possibility that a rickettsia could be the pathogen,
the Rickettsia Unit in Marseilles (Professor D Raoult) was
consulted.  Immunohistochemical stains for rickettsiae were
negative.2
Finally, the Molecular Department at the Onderstepoort
Veterinary Institute was consulted.  Tissue samples and serum
were examined, revealing the presence of Ehrlichia ruminantium
DNA sequences in all the samples.1
After the initial 2 cases, a possible third case came to our
attention.  Serum from this child was also evaluated at
Onderstepoort.  Unfortunately the child died before results
were available.  E. ruminantium DNA sequences were also
present in this case.  
Recently serum from a child who died in the Cape Town
region was also sent to Onderstepoort. This child also
presented with encephalitis, with hypodense lesions on CT
scan.  The child had a rapidly fatal clinical course. Again E.
ruminantium DNA sequences were retrieved from the serum
sample.
All the cases but the first have several similarities.  Most of
the patients were young children between the ages of 4 and 7
years.  All the children presented with a clinical picture of
encephalitis and had a rapidly fatal clinical course.  
After the first cases extensive enquiries were made into the
habits of the children.  All had lived close to agricultural
holdings or nature reserves and engaged in outdoor activities.
E. ruminantium is transported by ticks and causes heartwater
fever in ruminants.  Currently there are no records in the
literature of E. ruminantium infection in humans, although there
is one report of a possible canine E. ruminantium infection.3
However, the DNA sequence evidence from all the cases and
brain lesions typical of those seen in heartwater-infected
animals strongly suggest E. ruminantium infection. 
There is no molecular evidence of E. chaffiensis in South
Africa, for which the main target cells are monocytes4 rather
than the vascular endothelial cells observed in the current
infections. 
Ruminants infected with E. ruminantium are treated with
doxycycline.  Currently the only suggested way of treating this
in human patients is with oral doxycycline which,
unfortunately, is not always well tolerated.
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Elizabeth Wasserman, Associate Professor and Chairperson,
Department of Medical Microbiology, National Health
Laboratory Service, Coastal Branch, and Stellenbosch
University, comments: Tick-borne diseases are common and
serious, yet we know relatively little about their causative
agents, epidemiology and pathogenesis in South Africa. We are
familiar with the typical clinical presentation of tick-bite fever,
but it is difficult to confirm the causative agent in the routine
laboratory. Serology for rickettsial infection often remains
negative, even late in the disease, and the polymerase chain
reation (PCR), offered at many laboratories, lacks sensitivity.
Our knowledge of the so-called ‘African tick-bite fever’ caused
by Rickettsia africae and transmitted by Amblyomma ticks
originates mostly from cases reported from Europe in which
the disease was contracted while travelling in sub-Saharan
Africa. 
Human ehrlichiosis (caused by Ehrlichia chafeensis and E.
ewingii) is well described and frequently reported in the USA.1
Ehrlichiosis is often associated with mild to severe disease,2
with a mortality ranging from 2% to 3%, including healthy
children. E. ruminantium and its Amblyomma vectors have an
indiscriminate host range3 and human disease is therefore
conceivable. 
Many questions regarding the aetiology and epidemiology of
tick-borne disease in South Africa remain unanswered and
require further study. 
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To the Editor: We report on patients with ocular rhinospori-
diosis who attended the eye clinic at Umtata General Hospital.
No previous cases have been reported in the Xhosa-speaking
population.
Conjunctival rhinosporidiosis is a rare infectious disease that
typically occurs in young people. It was first described as a
pathogen in humans a century ago.1 The aetiological agent,
Rhinosporidium seeberi, commonly produces granulomatous
inflammation of the affected mucosa. Most reported ocular
infections have occurred in hot, dry climatic regions.2 The
diagnosis is usually made by biopsy and treatment is by
surgical excision. In South Africa cases have been reported
from KwaZulu-Natal.3,4
Material and methods
We reviewed medical records from January 1997 to December
2003 of patients treated at the eye clinic at Umtata General
Hospital with histopathological confirmation of
rhinosporidiosis. Six patients with rhinosporidiosis were
identified during this period. 
All our patients were of Xhosa origin. Three males and 3
females were affected. All were under the age of 15 years; 
1 was below the age of 5 years, 4 were between the ages 5 and
10 years, and 1 was above the age of 10 years. 
All patients presented with muco-purulent discharge from
the affected eyes and most also presented with a conjunctival
polypoid mass. One patient showed conjunctival chemosis and
1 presented with bleeding from the affected eye. No associated
nasal affection was seen in these patients. In keeping with
findings elsewhere, none of the cases was diagnosed clinically
as rhinosporidiosis.5
These lesions did not respond to antibiotic and anti-
inflammatory treatment. All were treated by surgical excision,
following which there were no recurrences and the patients
were asymptomatic. 
In all our patients there was conjunctival localisation, with
typically chronic non-granulomatous inflammation.
Histologically all stages of the organism’s life cycle could be
found in the excised tissue, from small trophocytes to large
sporangia-containing sporoblasts6 (Fig. 1).
Discussion
The conjunctival lesion of rhinosporidiosis was first described
in India in 1912.7 It is endemic in India, Sri Lanka and parts of
East Africa and South America and is caused by R. seeberi, an
endosporulating micro-organism.8 Although conjunctival
rhinosporidiosis is an infectious disease rarely recorded outside
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